Company Profile
XOMA Corporation Stock Price, News & Analysis
Company overview
Business overview
XOMA is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, XOMA is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
XOMA follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, XOMA sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
XOMA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
XOMA’s catalysts are royalty income, portfolio monetization, and any update that clarifies how the company is converting assets into value. The story is more about cash flow and capital allocation than pipeline risk.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
XOMA Royalty Enters into Agreement to Acquire Generation Bio
Source: XOMA Corporation
- 02
- 03
XOMA Royalty Announces CFO Transition
Source: XOMA Corporation
- 04
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
Source: XOMA Corporation
- 05
XOMA Royalty to Present at Investor Conferences in March
Source: XOMA Corporation
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.